4-158599395-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021634.4(RXFP1):c.356G>A(p.Arg119Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,613,266 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021634.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RXFP1 | NM_021634.4 | c.356G>A | p.Arg119Gln | missense_variant | 4/18 | ENST00000307765.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RXFP1 | ENST00000307765.10 | c.356G>A | p.Arg119Gln | missense_variant | 4/18 | 1 | NM_021634.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 151946Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000642 AC: 16AN: 249130Hom.: 0 AF XY: 0.0000740 AC XY: 10AN XY: 135170
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461320Hom.: 0 Cov.: 31 AF XY: 0.0000481 AC XY: 35AN XY: 726954
GnomAD4 genome AF: 0.0000921 AC: 14AN: 151946Hom.: 0 Cov.: 31 AF XY: 0.0000944 AC XY: 7AN XY: 74176
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2024 | The c.356G>A (p.R119Q) alteration is located in exon 4 (coding exon 4) of the RXFP1 gene. This alteration results from a G to A substitution at nucleotide position 356, causing the arginine (R) at amino acid position 119 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at